Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.38 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.36 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.36 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.36 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.36 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30366533 | 1.00 | L3MBTL1 (0.48) | L3MBTL1MAPTNPSR1HPGDATM | |
| SCHEMBL4860135 | 0.84 | LIPG (0.42) | NISCHADRA2AADRA2BADRA2C | |
| SCHEMBL30688760 | 0.83 | GABRA1 (0.39) | L3MBTL1MAPTNPSR1GABRA1GABRB2 | |
| SCHEMBL31611928 | 0.83 | L3MBTL1 (0.52) | L3MBTL1MAPTNPSR1HPGDATM | |
| SCHEMBL15636084 | 0.83 | L3MBTL1 (0.52) | L3MBTL1MAPTNPSR1HPGDATM | |
| SCHEMBL11092148 | 0.82 | GABRA1 (0.42) | L3MBTL1MAPTNPSR1HPGDATM | |
| SCHEMBL3968465 | 0.81 | LIPG (0.51) | — | |
| SCHEMBL12539477 | 0.81 | L3MBTL1 (0.43) | L3MBTL1MAPTNPSR1HPGDATM | |
| SCHEMBL30098805 | 0.81 | APOBEC3G (0.40) | TSHRKDM4EENPP2ORAI1ORAI2 | |
| SCHEMBL8558374 | 0.81 | APOBEC3G (0.40) | TSHRKDM4EENPP2ORAI1ORAI2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117816241-A | Palladium-containing catalyst, preparation method and application thereof, and Suzuki-Miyaura reaction method | 中国石油化工股份有限公司 | 2024-04-05 | — | — | CN | claimed |
| WO-2010146176-A2 | PROCESS FOR HYDROGENATION OF HALOGENOALKENES WITHOUT DEHALOGENATION | LEK PHARMACEUTICALS D.D. (SI) | 2010-12-23 | — | — | WO | claimed |
| CN-117816241-A | Palladium-containing catalyst, preparation method and application thereof, and Suzuki-Miyaura reaction method | 中国石油化工股份有限公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-101821246-B | Tetrazole-substituted arylamide derivatives and uses thereof | HOFFMANN LA ROCHE | 2013-05-01 | — | — | CN | disclosed |
| EP-2443129-A2 | PROCESS FOR HYDROGENATION OF HALOGENOALKENES WITHOUT DEHALOGENATION | LEK Pharmaceuticals d.d. (SI) | 2012-04-25 | — | — | EP | disclosed |
| EP-2443128-A2 | New synthetic route for the preparation of alpha-amino boronic esters | LEK Pharmaceuticals d.d. (SI) | 2012-04-25 | — | — | EP | disclosed |
| WO-2010146176-A2 | PROCESS FOR HYDROGENATION OF HALOGENOALKENES WITHOUT DEHALOGENATION | LEK PHARMACEUTICALS D.D. (SI) | 2010-12-23 | — | — | WO | disclosed |
| WO-2010146172-A2 | NEW SYNTHETIC ROUTE FOR THE PREPARATION OF α-AMINO BORONIC ACID DERIVATIVES VIA SUBSTITUTED ALK-1-YNES | LEK PHARMACEUTICALS D.D. (SI) | 2010-12-23 | — | — | WO | disclosed |
| CN-101821246-A | Tetrazole-substituted arylamide derivatives and uses thereof | HOFFMANN LA ROCHE | 2010-09-01 | — | — | CN | disclosed |
| WO-2009111290-A2 | METHOD FOR THE ELECTROCHEMICAL DEPOSITION OF CARBON NANOTUBES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-09-11 | — | — | WO | disclosed |
| EP-0675118-B1 | Biphenylderivatives, process for their preparation and their use as medicaments | EISAI CO LTD (JP) | 2002-10-09 | — | — | EP | disclosed |
| US-6281214-B1 | USEFUL FOR TREATING AND AMELIORATING MENTAL DISORDERS | EISAI CO., LTD (JP) | 2001-08-28 | — | — | US | disclosed |
| EP-0675118-A2 | Biphenylderivatives, process for their preparation and their use as medicaments | Eisai Co., Ltd. (JP) | 1995-10-04 | — | — | EP | disclosed |